Publication date: July 2018
Source:Surgical Oncology Clinics of North America, Volume 27, Issue 3
Author(s): Claire Yue Li, H. Richard Alexander
Teaser
Diffuse malignant peritoneal mesothelioma (MPM) is a rare cancer that is ultimately fatal in almost all afflicted individuals. Morbidity and mortality from MPM is due to its propensity to progress locoregionally within the abdominal cavity. Patients with MPM most commonly present with nonspecific abdominal symptoms that usually lead to diagnosis when the condition is relatively advanced. MPM is considered a chemotherapy-resistant malignancy.https://ift.tt/2yAP4ng
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου